Join
Live feed
·
INSIDERFilingvia Quantisnow
Mainz Biomed N.V. logo

Chief Executive Officer Lazar David E. converted options into 55,057,500 units of Ordinary Shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
QUCY· Mainz Biomed N.V.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QUCY (Mainz Biomed N.V.) and more on Quantisnow.